LDS/Medical Tests/Antibody Screen, Erythrocytes (RBC)

Antibody Screen, Erythrocytes (RBC)

An Antibody Screen is used to screen for antibodies to red blood cell (RBC) antigens present in plasma. The chance of antibody development to RBCs increases with multiple red cell infusions and pregnancies because of the increased exposure to foreign RBC antigens. The antibody screen testing in general identifies the presence of an antibody, but in itself cannot rule out or identify the specific antibody present. It is performed as part of a “type and screen” test for the possible need of a blood cell transfusion, and in pregnant women to monitor the possibility of hemolytic disease of the fetus and newborn (HDFN).

If an antibody is detected in the screening test, then an antibody identification test must be performed to determine which antibody or antibodies is present. The antibody screen is performed by mixing red blood cells of known antigenicity with patient plasma; if antibodies are present at or above a specific level, then agglutination will occur which is visually detected.

In the case of imminent transfusion, if antibodies are detected and identified, then donor blood must be screened to avoid transfusing the specific red blood cell antigen into the patient. In the case of evaluation for hemolytic disease of the fetus and newborn, if antibodies are detected and identified, continual monitoring of antibody identification and titer is indicated throughout the remainder of the patient’s pregnancy to evaluate ongoing potential risk to the fetus.

In addition, this test may be used as an aid in diagnosis of autoimmune related hemolytic anemia. This is a condition in which a person produces antibodies against their own RBC antigens, for example in systemic lupus erythematosus. Autoantibody to RBCs also can be detected in some blood malignancies such as lymphomas or chronic lymphocytic leukemia. It can also be detected in some infections, such as Mycoplasma pneumoniae and infectious mononucleosis. Autoimmune related hemolytic anemia can also be associated with use of certain medications. A medication history should be evaluated whenever investigating such cases.

  • Blood product recipient screening for the presence of unexpected allo- or autoantibodies (pre-transfusion testing)
  • In pregnant women to evaluate for possible hemolytic disease of the newborn

Positive in:

  • Presence of unexpected alloantibody or autoantibodies
  • Some infections such as mycoplasma pneumonia and infectious mononucleosis
  • Some disease states with high levels of protein can cause positive reactions at specific testing phases
  • Some specific medications can cause positive antibody screens

*Note: Clinical considerations together with laboratory data should dictate the extent to which a positive antibody screen is evaluated.

Some irregular alloantibodies, such as Kidd antibodies, fluctuate in strength making them difficult to detect and sometimes impossible to detect, even in a patient with a prior history of them.

Negative (no antibody detected)
 

 

Hemagglutination, immune diffusion (gel), antigen-antibody reaction

Sample Type

Whole Blood EDTA (K2) - (Lavender)

Temperature

  • Refrigerated: 7 days
Antibody identification testing should be performed to determine the presence of the specific antibody(s) and/or complements. Identification will aid in determining the significance of the screen, and is used to determine specific testing for donor red cells. The direct antiglobulin test (DAT) can provide data to indentify autoantibody complications. Passively administered antibody (especially Rho immune globulin) may produce a transiently positive antibody screening testing owing to circulation of the injected antibody.
Same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Technical Manual of the American Association of Blood Banks, 16th ed. American Association of Blood Banks, 2008.
  • J Gynecol Obstet Biol Reprod (Paris). 2004 Nov;33(7):637-48. [PMID: 15550883]
  • Transfusion. 2007 May;47(5):911-7. [PMID: 17465958]